Neurogene Inc

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Neurogene Inc and other ETFs, options, and stocks.

About NGNE

Neurogene, Inc. is a clinical-stage biotechnology company, which engages in the development of product portfolio of genetic medicines for rare neurological diseases. The company was founded in May 2007 and is headquartered in New York, NY. 

CEO
Rachel L. McMinn
CEORachel L. McMinn
Employees
107
Employees107
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2007
Founded2007
Employees
107
Employees107

NGNE Key Statistics

Market cap
219.78M
Market cap219.78M
Price-Earnings ratio
-3.35
Price-Earnings ratio-3.35
Dividend yield
—
Dividend yield—
Average volume
261.23K
Average volume261.23K
High today
$15.67
High today$15.67
Low today
$14.85
Low today$14.85
Open price
$15.12
Open price$15.12
Volume
142.44K
Volume142.44K
52 Week high
$74.49
52 Week high$74.49
52 Week low
$6.88
52 Week low$6.88

Analyst ratings

100%

of 7 ratings
Buy
100%
Hold
0%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.